The Spaniards drink Rioja wine with a hearty “Salud!,” while the Irish knock back Jameson whiskey and Guinness beer with “Slainte.” Nobody can say who coined the two calls to imbibe, both of which mean “health,” but according to two recent studies, it looks as though they were on to something.
The news that CVS Caremark's Pharmacy Advisor program has been recognized by the Pharmacy Benefit Management Institute is yet one more illustration of how the company has positioned itself along the front lines to leverage its various points of care to improve outcomes and lower healthcare costs.
As one retail pharmacy executive put it, "many members of Congress only experience the pharmacy industry through their eyes as a patient." Thanks to NACDS RxImpact Day on Capitol Hill, however, that no longer has to be the case.
If an ounce of prevention is worth a pound of cure, then that means 200 sq. ft. of retail pharmacy is the equivalent to acres of doctors' offices and medical clinics. If inhibitive cost, lack of awareness and prohibitive access represent the reasons behind why more people don’t get vaccinated, then pharmacy provides the all-in-one solution — because pharmacy can help eclipse each one of those vaccine barriers.
A drug used to treat high cholesterol, which will lose patent protection and face generic competition starting this year, also may help prevent blindness in people with diabetes, according to a study by researchers at the University of Georgia.